190 related articles for article (PubMed ID: 15479882)
1. Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease.
Buckley CD; Filer A; Haworth O; Parsonage G; Salmon M
Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii92-ii95. PubMed ID: 15479882
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology of rheumatoid arthritis].
Morović-Vergles J
Reumatizam; 2003; 50(2):15-7. PubMed ID: 15098367
[TBL] [Abstract][Full Text] [Related]
3. [Modern treatment of rheumatoid arthritis].
Surányi P
Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334
[TBL] [Abstract][Full Text] [Related]
4. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
5. Synovial fibroblasts: key players in rheumatoid arthritis.
Huber LC; Distler O; Tarner I; Gay RE; Gay S; Pap T
Rheumatology (Oxford); 2006 Jun; 45(6):669-75. PubMed ID: 16567358
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
Yamaguchi Y; Yamamoto K
Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of rheumatoid arthritis.
Rindfleisch JA; Muller D
Am Fam Physician; 2005 Sep; 72(6):1037-47. PubMed ID: 16190501
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis].
Tanaka Y; Suzuki K; Saito K
Clin Calcium; 2007 Apr; 17(4):593-9. PubMed ID: 17404490
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production.
Zhu P; Ding J; Zhou J; Dong WJ; Fan CM; Chen ZN
Arthritis Res Ther; 2005; 7(5):R1023-33. PubMed ID: 16207318
[TBL] [Abstract][Full Text] [Related]
10. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts.
Müller-Ladner U; Ospelt C; Gay S; Distler O; Pap T
Arthritis Res Ther; 2007; 9(6):223. PubMed ID: 18177509
[TBL] [Abstract][Full Text] [Related]
11. Synovial cell activation.
Stanczyk J; Ospelt C; Gay RE; Gay S
Curr Opin Rheumatol; 2006 May; 18(3):262-7. PubMed ID: 16582690
[TBL] [Abstract][Full Text] [Related]
12. [Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?].
Morović-Vergles J
Reumatizam; 2008; 55(2):70-2. PubMed ID: 19024280
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis in a military aviator.
Moszyk DJ; Sulit DJ
Aviat Space Environ Med; 2007 Jan; 78(1):63-6. PubMed ID: 17225486
[TBL] [Abstract][Full Text] [Related]
14. Stroma: fertile soil for inflammation.
Patel R; Filer A; Barone F; Buckley CD
Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):565-76. PubMed ID: 25481550
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
17. Early rheumatoid arthritis.
Mitchell KL; Pisetsky DS
Curr Opin Rheumatol; 2007 May; 19(3):278-83. PubMed ID: 17414956
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory arthritis: an overview for primary care physicians.
Brent LH
Postgrad Med; 2009 Mar; 121(2):148-62. PubMed ID: 19332973
[TBL] [Abstract][Full Text] [Related]
19. Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S.
Weidauer E; Yasuda Y; Biswal BK; Cherny M; James MN; Brömme D
Biol Chem; 2007 Mar; 388(3):331-6. PubMed ID: 17338641
[TBL] [Abstract][Full Text] [Related]
20. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
